Opinion: The Slow Start Is Not a Delay — Rethinking How We Talk About Rybelsus Titration
Patients starting oral semaglutide are often in a hurry to reach a higher dose, and the pressure to accelerate rarely gets examined. This opinion piece argues for calmer, more explicit conversations about titration pace, gastrointestinal side effects, and what shared decision-making should actually sound like in a U.S. clinic.